Kornel Galgoczy

Title: **Innovator Spotlight: Kornel Galgoczy**

Introduction

Kornel Galgoczy is a notable inventor based in Budapest, Hungary. With a unique contribution to the field of medicinal chemistry, he has developed a significant innovation that is poised to impact pharmaceutical applications.

Latest Patents

Kornel Galgoczy holds a patent for "4-benzylidene-piperidin derivatives." This invention pertains to novel 4-benzylidene-piperidin derivatives of formula (I), which are recognized as NMDA receptor antagonists that specifically target the NR2B subunit. Additionally, these compounds have promising analgesic properties, indicating their potential use in pain management therapies.

Career Highlights

He is currently associated with Richter Gedeon Vegyeszeti Gyar Rt., a prominent pharmaceutical company in Hungary. His work at the company underscores his commitment to advancing drug discovery and development in the healthcare sector.

Collaborations

Throughout his career, Kornel has collaborated with esteemed colleagues, including Istvan Borza and Csilla Horvath. These partnerships have fostered a collaborative environment that nurtures innovation and accelerates the development of cutting-edge therapeutic solutions.

Conclusion

Kornel Galgoczy’s contributions to the field of medicinal chemistry exemplify the spirit of innovation. His patent on 4-benzylidene-piperidin derivatives is a testament to the importance of research and collaboration in the pursuit of novel therapeutics. As he continues his work with Richter Gedeon, it will be exciting to see how his inventions evolve and contribute to the pharmaceutical landscape.